Founded
Address
Red Abbey Venture Partners LLC
2330 West Joppa Road
Suite 330
Baltimore, MD 21093
United States
Phone
Website
Recent investment activity
KANDO id: 2710
Corporate information
Official name
Red Abbey Venture Partners LLC
Registration country
Funding rounds
Actual initial investment stage
Series C (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 26| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Arginetix Inc | Biopharmaceutical company dedicated to developing and commercializing novel therapeutic small molecule inhibitors of arginase. | N/A | |||
|
|
CoGenesys Inc | N/A | ||||
|
|
Concentric Medical Inc | N/A | ||||
|
|
Corridor Pharmaceuticals Inc | N/A | ||||
|
|
Cyclacel Pharmaceutical Inc | Cell cycle control drugs for cancer. IPO in January 2006. | N/A | |||
|
|
Cytokinetics Inc | N/A | ||||
|
|
Dynavax Technologies Corp | N/A | ||||
|
|
Favrille Inc | N/A | ||||
|
|
Inhibitex Inc | N/A | ||||
|
|
Insulet Corp | N/A | ||||
|
|
Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | N/A | |||
|
|
Kanisa Pharmaceuticals Inc | Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. | N/A | |||
|
|
Kemia Inc | N/A | ||||
|
|
Metabasis Therapeutics Inc | Biopharmaceutical company focused on the discovery, development & commercialization of novel small molecule therapies drugs for diseases of the liver. | N/A | |||
|
|
Nereus Pharmaceuticals Inc | N/A | ||||
|
|
NicOx SA | Biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs. | N/A | |||
|
|
Oxagen Ltd | N/A | ||||
|
|
Santarus Inc | Drug company focused on gastrointestinal diseases and disorders. | N/A | |||
|
|
Stromedix Inc | A biotechnology company committed to developing novel drugs to treat fibrotic organ failure. | N/A | |||
|
|
Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | N/A | |||
|
|
Aegerion Pharmaceuticals Inc | N/A | ||||
|
Alba Therapeutics Corp | N/A | ||||
|
Anacor Pharmaceuticals Inc | Series C Initial investment | ||||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | N/A | |||
|
Merrimack Pharmaceuticals Inc | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Frank Bonsal | [email protected] | |||
| Jigar Raythatha | [email protected] | |||
| Matt Zuga | [email protected] | |||
| Philip Goelet | ||||
| Joseph Klein |